Eukaryotic mRNA 3' processing: a common means to different ends.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

49 citing papers in PubMed.

1. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.International journal of molecular sciences · 2022
   Review
2. RNA biology · 2021
   Article
3. U7 deciphered: the mechanism that forms the unusual 3' end of metazoan replication-dependent histone mRNAs.Biochemical Society transactions · 2021
   Review
4. The role of Mediator and Little Elongation Complex in transcription termination.Nature communications · 2020
   Article
5. Transcription Terminator-Mediated Enhancement in Transgene Expression in Maize: Preponderance of the AUGAAU Motif Overlapping With Poly(A) Signals.Frontiers in plant science · 2020
   Article
6. Importance of amino acids Leu135 and Tyr236 for the interaction between EhCFIm25 and RNA: a molecular dynamics simulation study.Journal of molecular modeling · 2018
   Article
7. An intronless form of the tobacco extensin gene terminator strongly enhances transient gene expression in plant leaves.Plant molecular biology · 2018
   Article
8. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.PLoS pathogens · 2017
   Article
9. Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.Journal of microbiology (Seoul, Korea) · 2017
   Article
10. Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end.Pflugers Archiv : European journal of physiology · 2016
    Review
11. 3'-End processing of histone pre-mRNAs in Drosophila: U7 snRNP is associated with FLASH and polyadenylation factors.RNA (New York, N.Y.) · 2013
    Article
12. Quantification of stochastic noise of splicing and polyadenylation in Entamoeba histolytica.Nucleic acids research · 2013
    Article
13. A complex containing the CPSF73 endonuclease and other polyadenylation factors associates with U7 snRNP and is recruited to histone pre-mRNA for 3'-end processing.Molecular and cellular biology · 2013
    Article
14. Plant polyadenylation factors: conservation and variety in the polyadenylation complex in plants.BMC genomics · 2012
    Article
15. A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression.The EMBO journal · 2012
    Article
16. From miracle fruit to transgenic tomato: mass production of the taste-modifying protein miraculin in transgenic plants.Plant cell reports · 2012
    Review
17. The role of CYP3A4 mRNA transcript with shortened 3'-untranslated region in hepatocyte differentiation, liver development, and response to drug induction.Molecular pharmacology · 2012
    Article
18. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.Journal of virology · 2011
    Article
19. MiniSOX9, a dominant-negative variant in colon cancer cells.Oncogene · 2011
    Article
20. High-level accumulation of recombinant miraculin protein in transgenic tomatoes expressing a synthetic miraculin gene with optimized codon usage terminated by the native miraculin terminator.Plant cell reports · 2011
    Article

Corrections and comments

• Comment on
  Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs.2005

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as